News 社会の激動 2015年1月1日 Nature Biotechnology 33, 1 doi: 10.1038/nbt.3106 The drug industry is struggling to find ways of engaging with consumers on social media. Failure to adapt may bring substantial opportunity costs, argues Virginia Hughes. Full text PDF 目次へ戻る
